Menu Menu

RSLS    Reshape Lifesciences Inc    1427570    
Income Statement
Revenue rsls-20240930x10q 2,292,000
Net Income rsls-20240930x10q -1,581,000
Profit Margin -68.98%

Balance Sheet
Current Assets 5,338,000
Assets 5,615,000
Current Liabilities 4,025,000
Liabilities 4,128,000
Equity 1,487,000
Shares Out 29,387,000

Cash Flow Statement
Operating Cash Flow -3,740,000

Market Analysis
Market Cap 4,760,019
Price 0.73
BVPS 0.05
PB 12.45
EPS -1.29
PS 0.52
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
Apr May Jun
4/01 5/15
Jul Aug Sep
8/14 -0.06
Oct Nov Dec
11/14 -3.11

Find a discrepancy? The most accurate way to find company fundamental data is to view RSLS documents filed with the SEC.


RSLS Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas